Abstract
Xanthohumol is a prenylated flavonoid derived from the female flowers of the hop plant (Humulus lupulus L.) species in the family Cannabaceae, with potential pharmacological activities. Xanthohumol, a bitter tasting compound, belongs to a flavonoid class of secondary metabolites and particularly to a subclass of chalcone precursors of flavonoids. Investigations by academic and industrial scientists have generated keen interest in its useful properties in food, beverages, and medicine. Animal and human studies of xanthohumol have revealed its diverse biological features, including anti-inflammatory, anti-cancer, anti-oxidant, and anti-diabetic activities, as well as other related properties. The safety of xanthohumol is almost guaranteed, as there is an abundance of data demonstrating its safe use in food and beverages. Xanthohumol and xanthohumol-rich extracts from hops have proven their worth in clinical trials as well as marketed products.
References
Agrawal A (2011) Pharmacological activities of flavonoids: a review. Int J Pharm Sci Nanotechnol 4:1394–1398
Agrawal R, Sethiya NK, Mishra SH (2013) Antidiabetic activity of alkaloids of Aerva lanata roots on streptozotocin-nicotinamide induced type-II diabetes in rats. Pharm Biol 51:635–642
Allen PC (2007) Anticoccidial effects of xanthohumol. Avian Dis 2:21–26
Almaguer C, Schönberger C, Gastl M, Arendt EK, Becker T (2014) Humulus lupulus – a story that begs to be told. A review. J Inst Brew 120:289–314
Bai HH, Xia TS, Jiang YP, Xu WM, Xu PC, Wang NN, Gou XJ, Xin HL (2022) Absorption, metabolism, and pharmacokinetic profile of xanthohumol in rats as determined via UPLC-MS/MS. Biopharm Drug Dispos 43:11–22
Bana Z, Qin H, Mitchell AJ, Liu B, Zhang F, Weng J-K, Dixone RA, Wanga G (2018) Noncatalytic chalcone isomerase-fold proteins in Humulus lupulus are auxiliary components in prenylated flavonoid biosynthesis. Proc Natl Acad Sci U S A 115:E5223–E5232
Barnes J, Anderson LA, Phillipson JD (2007) Herbal medicines, 3rd edn. Pharmaceutical Press, London
Behnam D (2019) Solubilisate with curcumin, xanthohumol and licorice root extract. WO2019011415A1
Benelli R, Ven R, Ciarlo M, Carlone S, Barbieri O, Ferrari N (2012) The AKT/NF-κB inhibitor xanthohumol is a potent anti-lymphocytic leukemia drug overcoming chemoresistance and cell infiltration. Biochem Pharmacol 83:1634–1642
Blumenthal M, Busse WR (1998) The complete German Commission E monographs: therapeutic guide to herbal medicines/developed by a Special Expert Committee of the German Federal Institute for Drugs and Medical Devices; senior editor, Mark Blumenthal; associate editors, Werner R. Busse et al.; primary translator, Sigrid Klein; associate translator, Robert S. Rister; with a foreword by Varro E. Tyler. – Version details – Trove. (W. R. Blumenthal, Mark Busse, Ed.). American Botanical Council/Integrative Medicine Communications, Austin/Boston
Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-gamma. Ann Rev Immunol 15:749
Całkosińska A, Dominiak M, Sobolewska S, Leśków A, Tarnowska M, Całkosiński A, Dobrzyński M (2020) The protective effect of xanthohumol on the content of selected elements in the bone tissue for exposed Japanese quails to TCDD. Int J Environ Res Public Health 17:5883–5883
Campillo S, Rancan L, Paredes SD, Higuera M, Izquierdo A, García C, Forman K, Tresguerres JAF, Vara E (2018) Effect of treatment with xanthohumol on cardiological alterations secondary to ageing. J Funct Foods 49:44–51
Carvalho DO, Oliveira R, Johansson B, Guido LF (2016) Dose-dependent protective and inductive effects of xanthohumol on oxidative DNA damage in Saccharomyces cerevisiae. Food Technol Biotechnol 54:60–69
Cermak P, Olsovska J, Mikyska A, Dusek M, Kadleckova Z, Vanicek J, Nyc O, Sigler K, Bostikova V, Bostik P (2017) Strong antimicrobial activity of xanthohumol and other derivatives from hops (Humulus lupulus) on gut anaerobic bacteria. APMIS 125:1033–1038
Cho YC, Kim HJ, Kim YJ, Lee KY, Choi HJ, Lee IS, Kang BY (2008) Differential anti-inflammatory pathway by xanthohumol in IFN-γ and LPS-activated macrophages. Int Immunopharmacol 8:567–573
Costa R, Negrão R, Valente I, Castela Â, Duarte D, Guardão L, Magalhães PJ, Rodrigues JA, Guimarães JT, Gomes P, Soares R (2013) Xanthohumol modulates inflammation, oxidative stress, and angiogenesis in type I diabetic rat skin wound healing. J Nat Prod 76:2047–2053
Dokduang H, Yongvanit P, Namwat N, Pairojkul C, Sangkhamanon S, Yageta MS, Murakami Y, Loilome W (2016) Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells. Oncol Rep 35:2065–2072
Dorn C, Bataille F, Gaebele E, Heilmann J, Hellerbrand C (2010) Xanthohumol feeding does not impair organ function and homoeostasis in mice. Food Chem Toxicol 48:1890–1897
Dorn C, Heilmann J, Hellerbrand C (2012) Protective effect of xanthohumol on toxin-induced liver inflammation and fibrosis. Int J Clin Exp Pathol 5:29–36
Dorn C, Massinger S, Wuzik A, Heilmann J, Hellerbrand C (2013) Xanthohumol suppresses inflammatory response to warm ischemia–reperfusion induced liver injury. Exp Mol Pathol 94:10–16
Erhardt PW, Khupse RS (2008) Method for synthesizing xanthohumol. WO2009026206A1
Ferk F, Mišík M, Nersesyan A, Pichler C, Jäger W, Szekeres T, Marculescu R, Poulsen HE, Henriksen T, Bono R, Romanazzi V, Al-Serori H, Biendl M, Wagner K-H, Kundi M, Knasmüller S (2016) Impact of xanthohumol (a prenylated flavonoid from hops) on DNA stability and other health-related biochemical parameters: results of human intervention trials. Mol Nutr Food Res 60:773–786
Fernández-García C, Rancan L, Paredes SD, Montero C, de la Fuente M, Vara E, Tresguerres JAF (2019) Xanthohumol exerts protective effects in liver alterations associated with aging. Eur J Nutr 58:653–663
Forster A, Schulmeyr J, Schmidt R, Simon K, Ketterer M, Forchhammer B, Geyer S, Gehrig M (2014) Method of producing a xanthohumol-concentrated hop extracted and use thereof. US 2004/0121040A1
Fournial A (2010) Cosmetic and topical use of xanthohumol including brightening skin complexion and reducing cutaneous redness. WO/2010/044076
Gallo C, Dallaglio K, Bassani B, Rossi T, Rossello A, Noonan DM, D’Uva G, Bruno A, Albini A (2016) Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation. Oncotarget 7:59917–59931
Grieve M (1971) A modern herbal: the medicinal, culinary, cosmetic, and economic properties, cultivation, and folk-lore of herbs, grasses, fungi, shrubs, & trees with all their modern scientific uses. Dover Publications, New York
Guerreiro S, Monteiro R, Martins MJ, Calhau C, Azevedo I, Soares R (2007) Distinct modulation of alkaline phosphatase isoenzymes by 17beta-estradiol and xanthohumol in breast cancer MCF-7 cells. Clin Biochem 40:268–273
Hanske L, Loh G, Sczesny S, Blaut M, Braune A (2010) Recovery and metabolism of xanthohumol in germ-free and human microbiota-associated rats. Mol Nutr Food Res 54:1405–1413
Hellerbrand C (2013) Use of xanthohumol or isoxanthohumol as an active substance for the prevention and/or control of liver diseases. CA2672155A1
Huang X, Wang J, Chen X, Liu P, Wang S, Song F, Zhang Z, Zhu F, Huang X, Liu J, Song G, Spencer PS, Yang X (2018) The prenylflavonoid xanthohumol reduces Alzheimer-like changes and modulates multiple pathogenic molecular pathways in the Neuro2a/APPswe cell model of AD. Front Pharmacol 9:199
Hussong R, Frank N, Knauft J, Ittrich C, Owen R, Becker H, Gerhäuser C (2005) A safety study of oral xanthohumol administration and its influence on fertility in Sprague Dawley rats. Mol Nutr Food Res 49:861–867
Jamnongkan W, Thanee M, Yongvanit P, Loilome W, Thanan R, Kimawaha P, Boonmars T, Silakit R, Namwat N, Techasen A (2018) Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis. PeerJ 6:e4281
Jiang W, Zhao S, Xu L, Lu Y, Lu Z, Chen C, Ni J, Wan R, Yang L (2015) The inhibitory effects of xanthohumol, a prenylated chalcone derived from hops, on cell growth and tumorigenesis in human pancreatic cancer. Biomed Pharmacother 73:40–47
Jiang C-H, Sun T-L, Xiang D-X, Wei S-S, Li W-Q (2018) Anticancer activity and mechanism of xanthohumol: a prenylated flavonoid from hops (Humulus lupulus L.). Front Pharmacol 9:530
Keiler AM, Dörfelt P, Chatterjee N, Helle J, Bader MI, Vollmer G, Kretzschmar G, Kuhlee F, Thieme D, Zierau O (2015) Assessment of the effects of naringenin-type flavanones in uterus and vagina. J Steroid Biochem Mol Biol 145:49–57
Khatib N, Varidi MJ, Mohebbi M, Varidi M, Hosseini SMH (2020) Replacement of nitrite with lupulon–xanthohumol loaded nanoliposome in cooked beef-sausage: experimental and model based study. J Food Sci Technol 57:2629–2639
Krajka-Kuźniak V, Cykowiak M, Szaefer H, Kleszcz R, Baer-Dubowska W (2020) Combination of xanthohumol and phenethyl isothiocyanate inhibits NF-κB and activates Nrf2 in pancreatic cancer cells. Toxicol In Vitro 65:104799
Langley BO, Ryan JJ, Hanes D, Phipps J, Stack E, Metz TO, Stevens JF, Bradley R (2021) Xanthohumol microbiome and signature in healthy adults (the XMaS trial): safety and tolerability results of a phase I triple-masked, placebo-controlled clinical trial. Mol Nutr Food Res 65:2001170
Lee I-S, Lim J, Gal J, Kang JC, Kim HJ, Kang BY, Choi HJ (2011) Anti-inflammatory activity of xanthohumol involves heme oxygenase-1 induction via NRF2-ARE signaling in microglial BV2 cells. Neurochem Int 58:153–160
Legette L, Karnpracha C, Reed RL, Choi J, Bobe G, Christensen JM, Rodriguez-Proteau R, Purnell JQ, Stevens JF (2014) Human pharmacokinetics of xanthohumol, an antihyperglycemic flavonoid from hops. Mol Nutr Food Res 58:248–255
Leśków A, Tarnowska MG, Rosińczuk J, Dobrzyński M, Kaliszewski K, Majda J, Żybura-Wszol̷a K, Sobolewska S, Diakowska D (2020) Xanthohumol effect on 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated Japanese quails in terms of serum lipids, liver enzymes, estradiol, and thyroid hormones. ACS Omega 5:24445–24452
Li H, Ban Z, Qin H, Ma L, King AJ, Wang G (2015) A heteromeric membrane-bound prenyltransferase complex from hop catalyzes three sequential aromatic prenylations in the bitter acid pathway. Plant Physiol 167:650–659
Lima-Fontes M, Costa R, Rodrigues I, Soares R (2017) Xanthohumol restores hepatic glucolipid metabolism balance in type 1 diabetic wistar rats. J Agric Food Chem 65:7433–7439
Liu M, Yin H, Liu G, Dong J, Qian Z, Miao J (2014) Xanthohumol, a prenylated chalcone from beer hops, acts as an α-glucosidase inhibitor in vitro. J Agric Food Chem 62:5548–5554
Logan IE, Shulzhenko N, Sharpton TJ, Bobe G, Liu K, Nuss S, Jones ML, Miranda CL, Vasquez-Perez S, Pennington JM, Leonard SW, Choi J, Wu W, Gurung M, Kim JP, Lowry MB, Morgun A, Maier CS, Stevens JF, Gombart AF (2021) Xanthohumol requires the intestinal microbiota to improve glucose metabolism in diet-induced obese mice. Mol Nutr Food Res 65:e2100389
Ma S, Zhang R, Li L, Qu H, Wang J, Yang Q, Guo C, Miao S, Shi X (2021) Xanthohumol protect cognitive performance in diabetic model rats by inhibiting protein kinase B/nuclear factor kappa-B pathway. Neuroreport 32:651–658
Maragou NC, Rosenberg E, Thomaidis NS, Koupparis MA (2008) Direct determination of the estrogenic compounds 8-prenylnaringenin, zearalenone, alpha- and beta-zearalenol in beer by liquid chromatography-mass spectrometry. J Chromatogr A 1202:47–57
Miranda CL, Johnson LA, de Montgolfier O, Elias VD, Ullrich LS, Hay JJ, Paraiso IL, Choi J, Reed RL, Revel JS, Kioussi C, Bobe G, Iwaniec UT, Turner RT, Katzenellenbogen BS, Katzenellenbogen JA, Blakemore PR, Gombart AF, Maier CS, Raber J, Stevens JF (2018) Non-estrogenic xanthohumol derivatives mitigate insulin resistance and cognitive impairment in high-fat diet-induced obese mice. Sci Rep 8:613
Monteiro R, Calhau C, Silva AOE, Pinheiro-Silva S, Guerreiro S, Gärtner F, Azevedo I, Soares R (2008) Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts. J Cell Biochem 104:1699–1707
Morad M, Cleemann L, Arnaiz-Cot JJ (2018) Xanthohumol in antiarrythmic applications. US20170304220A1
Motyl M (2013) The absorption of xanthohumol in in vitro and in vivo studies and the investigation of the biological activity of structurally related chalcones. Thesis, University of Regensburg, Germany
Mukai R (2018) Prenylation enhances the biological activity of dietary flavonoids by altering their bioavailability. Biosci Biotechnol Biochem 82:207–215
Nagel J, Culley LK, Lu Y, Liu E, Matthews PD, Stevens JF, Page JE (2008) EST analysis of hop glandular trichomes identifies an O-methyltransferase that catalyzes the biosynthesis of xanthohumol. Plant Cell 20:186–200
Ngaki MN, Louie GV, Philippe RN, Manning G, Pojer F, Bowman ME, Li L, Larsen E, Wurtele ES, Noel JP (2012) Evolution of the chalcone-isomerase fold from fatty-acid binding to stereospecific catalysis. Nature 485:530–533
Novák P, Matousek J, Bríza J (2003) Valerophenone synthase-like chalcone synthase homologues in Humulus lupulus. Biol Plant 46:375–381
Nowak B, Poźniak B, Popłoński J, Bobak Ł, Matuszewska A, Kwiatkowska J, Dziewiszek W, Huszcza E, Szeląg A (2020) Pharmacokinetics of xanthohumol in rats of both sexes after oral and intravenous administration of pure xanthohumol and prenylflavonoid extract. Adv Clin Exp Med 29:1101–1109
Nozawa H (2005) Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-Ay mice. Biochem Biophys Res Commun 336:754–761
Ohishi K, Toume K, Arai MA, Koyano T, Kowithayakorn T, Mizoguchi T, Itoh M, Ishibashi M (2015) 9-Hydroxycanthin-6-one, a β-carboline alkaloid from Eurycoma longifolia, is the first Wnt signal inhibitor through activation of glycogen synthase kinase 3β without depending on casein kinase 1α. J Nat Prod 78:1139–1146
Okada Y, Sano Y, Kaneko T, Abe I, Noguchi H, Ito K (2004) Enzymatic reactions by five chalcone synthase homologs from hop (Humulus lupulus L.). Biosci Biotechnol Biochem 68:1142–1145
Paraiso IL, Plagmann LS, Yang L, Zielke R, Gombart AF, Maier CS, Sikora AE, Blakemore PR, Stevens JF (2019) Reductive metabolism of xanthohumol and 8-prenylnaringenin by the intestinal bacterium Eubacterium ramulus. Mol Nutr Food Res 63:1800923
Pichler C, Ferk F, Al-Serori H, Huber W, Jäger W, Waldherr M, Mišík M, Kundi M, Nersesyan A, Herbacek I, Knasmueller S (2017) Xanthohumol prevents DNA damage by dietary carcinogens: results of a human intervention trial. Cancer Prev Res 10:153–160
Pinto C, Duque AL, Rodríguez-Galdón B, Cestero JJ, Macías P (2012) Xanthohumol prevents carbon tetrachloride-induced acute liver injury in rats. Food Chem Toxicol 50:3405–3412
Power FB, Tutin F, Rogerson H (1913) CXXXV – the constituents of hops. J Chem Soc Trans 103:1267–1292
Rancán L, Paredes SD, García I, Muñoz P, García C, López de Hontanar G, de la Fuente M, Vara E, Tresguerres JAF (2017) Protective effect of xanthohumol against age-related brain damage. J Nutr Biochem 49:133–140
Robinson DR, Kalyana-Sundaram S, Wu YM, Shankar S, Cao X, Ateeq B, Asangani IA, Iyer M, Maher CA, Grasso CS et al (2011) Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat Med 17:1646–1651
Rudzitis-Auth J, Korbel C, Scheuer C, Menger MD, Laschke MW (2012) Xanthohumol inhibits growth and vascularization of developing endometriotic lesions. Hum Reprod 27:1735–1744
Sasaki H, Kashiwada Y, Shibatav H, Takaishi Y (2012) Prenylated flavonoids from the roots of Desmodium caudatum and evaluation of their antifungal activity. Planta Med 78(17):1851–1856
Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163–189
Seitz T, Hackl C, Freese K, Dietrich P, Mahli A, Thasler RM, Thasler WE, Lang SA, Bosserhoff AK, Hellerbrand C (2022) Xanthohumol, a prenylated chalcone derived from hops, inhibits growth and metastasis of melanoma cells. Cancers 13:511
Seliger JM, Misuri L, Maser E, Hintzpeter J (2018) The hop-derived compounds xanthohumol, isoxanthohumol and 8-prenylnaringenin are tight-binding inhibitors of human aldo-keto reductases 1B1 and 1B10. J Enzyme Inhib Med Chem 33:607–614
Sleha R, Radochova V, Mikyska A, Houska M, Bolehovska R, Janovska S, Pejchal J, Muckova L, Cermak P, Bostik P (2021) Strong antimicrobial effects of xanthohumol and beta-acids from hops against Clostridioides difficile infection in vivo. Antibiotics (Basel) 10(4):392
Sliekers AO, Brookmeyer KR, Verlinde CJA-S (2018) Anti-microbial agent comprising xanthohumol and the use thereof in food products. WO 2014/078521 A1
Stevens JF, Page JE (2004) Xanthohumol and related prenylflavonoids from hops and beer: to your good health! Phytochemistry 65:1317–1330
Stevens JF, Ivancic M, Hsu VL, Deinzer ML (1997) Prenylflavonoids from Humulus lupulus. Phytochemistry 44:1575–1585
Sun Z, Zhou C, Liu F, Zhang W, Chen J, Pan Y, Ma L, Liu Q, Du Y, Yang J, Wang Q (2018) Inhibition of breast cancer cell survival by Xanthohumol via modulation of the notch signaling pathway in vivo and in vitro. Oncol Lett 15:908–916
Tsurumaru Y, Sasaki K, Miyawaki T, Uto Y, Momma T, Umemoto N, Momose M, Yazaki K (2012) HlPT-1, a membrane-bound prenyltransferase responsible for the biosynthesis of bitter acids in hops. Biochem Biophys Res Commun 417:393–398
van Breemen RB, Yuan Y, Banuvar S, Shulman LP, Qiu X, Alvarenga RFR, Chen S-N, Dietz BM, Bolton JL, Pauli GF, Krause E, Viana M, Nikolic D (2014) Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hops. Mol Nutr Food Res 58:1962–1969
Vanhoecke BW, Delporte F, Van Braeckel E, Heyerick A, Depypere HT, Nuytinck M, De Keukeleire D, Bracke ME (2005) A safety study of oral tangeretin and xanthohumol administration to laboratory mice. In Vivo 19:103–107
Vene R, Benelli R, Minghelli S, Astigiano S, Tosetti F, Ferrari N (2012) Xanthohumol impairs human prostate cancer cell growth and invasion and diminishes the incidence and progression of advanced tumors in TRAMP mice. Mol Med 18(9):1292–1302
Venturelli S, Burkard M, Biendl M, Lauer UM, Frank J, Busch C (2016) Prenylated chalcones and flavonoids for the prevention and treatment of cancer. Nutrition 32:1171–1178
Verzele M, Stockx J, Fontijn F, Anteunis M (1957) Xanthohumol, a new natural chalkone. B Soc Chim Belg 66:452–475
Werner B, Achim Z, Sascha W (2014) Natural extract containing xanthohumol, and method for the production thereof and products produced therefrom. CA 2575793
Wyns C, Bolca S, De Keukeleire D, Heyerick A (2010) Development of a high-throughput LC/APCI-MS method for the determination of thirteen phytoestrogens including gut microbial metabolites in human urine and serum. J Chromatogr B Analyt Technol Biomed Life Sci 878:949–956
Yamaguchi N, Satoh-Yamaguchi K, Ono M (2009) In vitro evolution of antibacterial, anticollagenase, and antioxidant activities of hop components (Humulus lupulus) addressing acne vulgaris. Phytomedicine 16:369–376
Yang M, Li N, Li F, Zhu Q, Liu X, Han Q, Wang Y, Chen Y, Zeng X, Lv Y, Zhang P, Yang C, Liu Z (2013) Xanthohumol, a main prenylated chalcone from hops, reduces liver damage and modulates oxidative reaction and apoptosis in hepatitis C virus infected Tupaia belangeri. Int Immunopharmacol 16:466–474
Yoo YB, Park KS, Kim JB, Kang HJ, Yang JH, Lee EK, Kim HY (2014) Xanthohumol inhibits cellular proliferation in a breast cancer cell line (MDA-MB231) through an intrinsic mitochondrial-dependent pathway. Indian J Cancer 51:518–523
Yuan Y, Nikolic D, Wright B, Dahl JH, Van Breemen RB (2011) Quantitative analysis of hop prenylflavonoids in human serum using UHPLC-MS-MS. In: Proceedings of the 59th ASMS conference on mass spectrometry and allied topics, Denver, p 1267
Yuan J, Peng G, Xiao G, Yang Z, Huang J, Liu Q, Yang Z, Liu D (2020) Xanthohumol suppresses glioblastoma via modulation of Hexokinase 2-mediated glycolysis. J Cancer 11:4047–4058
Yui K, Kiyofuji A, Osada K (2014) Effects of xanthohumol-rich extract from the hop on fatty acid metabolism in rats fed a high-fat diet. J Oleo Sci 63:159–168
Zanoli P, Zavatti M (2008) Pharmacognostic and pharmacological profile of Humulus lupulus L. J Ethnopharmacol 116:383–396
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Awouafack, M.D., Lee, YE., Morita, H. (2023). Xanthohumol: Recent Advances on Resources, Biosynthesis, Bioavailability and Pharmacology. In: Xiao, J. (eds) Handbook of Dietary Flavonoids. Springer, Cham. https://doi.org/10.1007/978-3-030-94753-8_52-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-94753-8_52-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-94753-8
Online ISBN: 978-3-030-94753-8
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences